Page 4 of 5

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 11:08
by Kamal Rathinam
6. The maintainance dose of digoxin given is high(625 mcg). It should be reduced.

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 11:11
by Sherin
6. there is a decimal point error
the dose is 0.0625mg

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 11:19
by Sobana
14. There will be an drug enteral feeding interaction with this patient like
WARFARIN; There will be the possible decreases the absorption or interaction with vit-k in feeds
MANAGEMENT; *Closely moniter the international normalized ratio(INR)
*consider alternative method for anticoagulant
*STOP FEEDING 1 HOUR BEFORE AND AFTER WARFARIN ADMINISTRATION
*Dose adjustment should be done

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 11:28
by Prithika S I
question 2
Digoxin is considered safe to use in the elderly as long as the dose is no greater than 0.125 milligram (mg) or 125 mcg per day.
higher dose may cause Changes in mood and mental alertness, including confusion, depression and lost interest in usual activities
this may be the reason for her confused state

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 11:35
by Prithika S I
question 6
safe digoxin dose for elderly : not more than 125 mcg or 0.125 mg
here the patient is diven with a high dose of digoxin ( 0.625 mg )
it should be reduced

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 11:38
by Solomon Benny
pottassium chloride for patients with 2.4 mmol should be administerd with 10 Meq /mol.

too much pottasium can aggrevate arrythmic problems.

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 11:43
by Sherin
11.Concentrated potassium is a high risk medication.
Pharmacists and other health professionals involved in handling this high-risk product must ensure that it is stored and utilised in accordance with this policy in order to minimise the risk of its inadvertent or inaccurate administration.
In order to further minimise the risks posed by use of potassium strong injection (2mmol/ml), this presentation of potassium is only available in certain clinical areas within the Trust. Where potassium is required to be administered to patients outside of these clinical areas doctors must prescribe one of the pre-mixed infusion bags which are available

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 11:49
by Solomon Benny
9.infection at the site of injection
.chances of sysytemic infection
. allergic reactions are fast
. reddness ,pain ,swelling at site occurs
.damage to blood vessels ,phlebitis and inflammation of veins .
if air gets trapped in syringe : air embolism occurs
. blood clots are possible to form

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 11:58
by Solomon Benny
10 .pottasium chloride infusion should contain 10 -20 mmol max possible dose..with 0.9% sodium chloride
increase in dose can cause electrolyte imbalance .hperkalemia .also arrhythmic complications

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 12:04
by Solomon Benny
11.pottasium chloride 10 Meq are avaialable as otc .
high concentrations of pot chloride are not safe to keep in clinical araes..cz unintentional administration can cause life threatening conditions